Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): Randomised placebo-controlled trial

Lancet

Volumn 356, Issue 9237, 2000, Pages 1213-1218

  Boaz, M ^a,b   Smetana, S ^b   Weinstein, T ^d   Matas, Z ^b   Gafter, U ^d   Iaina, A ^e   Knecht, A ^f   Weissgarten, Y ^g   Brunner, D ^b   Fainaru, M ^a   Green, M S ^b,c  

^a TEL AVIV UNIVERSITY   (Israel)

^b E Wolfson Medical Centre   (Israel)

^c Israel Centre for Disease Control   (Israel)

^d RABIN MEDICAL CENTER   (Israel)

^e Ichilov Medical Center   (Israel)

^f SHEBA MEDICAL CENTER   (Israel)

^g ASSAF HAROFEH MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; CHOLESTEROL; CYANOCOBALAMIN; FOLIC ACID; HEMOGLOBIN; PYRIDOXINE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; HEART INFARCTION; HEMODIALYSIS; HEMOGLOBIN DETERMINATION; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NUTRITIONAL REQUIREMENT; OXIDATIVE STRESS; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; UNSTABLE ANGINA PECTORIS; VITAMIN SUPPLEMENTATION;

EID: 0034619027     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)02783-5     Document Type: Article

References (25)

1. Cardiac function and hematocrit level
2. Cardiac and cerebrovascular disease in chronic uremia
3. Morbidity and mortality due to hypertensive patients with renal failure
4. Lipid peroxidation on dialysis membranes
5. Effect of hemodialysis in lipid peroxidation and antioxidant systems in patients with chronic renal failure
6. Oxidative stress in hemodialysis
7. Serum malondialdehyde and prevalent cardiovascular disease in hemodialysis
8. Comparison of hemostatic factors and serum malondialdehyde as predictive factors for cardiovascular disease in hemodiaylsis patients
9. Increased susceptibility of LDL to in vitro oxidation in patients on maintenance hemodialysis: Effects of fish oil and vitamin E administration
10. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy
11. Effect of alpha-tocopherol on in vitro and in vivo metabolism of low density lipoproteins in hemodialysis patients
12. Effect of vitamin E on lipid metabolism and atherosclerosis in ESRD patients
13. Comparative studies on different methods of malondialdehyde determination
14. Automated colorimetric method for the determination of serum tocopherol
15. Second-generation logarithmic estimates of singlepool variable volume Kt/V; an analysis of error
16. Which diet for which renal failure: Making sense of the options
17. Randomised controlled trial of vitamin E in patients with coronary disease: Cambrige Heart Antioxidant Study (CHAOS)
18. Mortality in the CHAOS trial
19. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: Results of the GISSI-Prevenzione trial
20. Vitamin E and heart disease: Basic science to clinical interventions trials
21. Vitamin E supplementation and cardiovascular events in high-risk patients
22. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers
23. Vitamin E, a modifier of platelet function: Rationale and use in cardiovascular and cerebrovascular disease
24. The effects of alpha tocopherol on critical cells in atherogenesis
25. Antioxidants and atherosclerotic heart disease